CHRU de Brest
Brest, 29609, France
NCT Number: NCT03901664
To determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.
Looking for future studies?
Notify MeAll sexes
Observational
Brest, 29609, France
The goal of this study is to determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.
All patients who had an evaluation of their lymphocyte subpopulations between january 2010 and december 2016 will be included in a retrospective analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: an average of 1 year
Diagnosis (systemic lupus erythematosus, primary Sjopgren's ....) according to current ACR/EULAR criteria
Looking for future studies?
Notify MeUniversity Hospital, Brest
Other
Lymphocyte Sub-populations and Auto Immune Diseases : What Type of Profile ? (SPLIT)
Acronym: SPLIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04902807
APECED, Arthritis
Paris, France
View Trial DetailsNCT06587828
Ankylosing Spondylitis, Ankylosis
Orange, California, United States
View Trial DetailsNCT05777499
Acquired Brain Injury, Autoimmune Diseases
London, United Kingdom
View Trial DetailsNCT05016700
Autoimmune Diseases, Defecation Disorder
Cologne, North Rhine-Westphalia, Germany
View Trial Details